1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CPGI-C005, CPGI-C005-CPG7909, CPGI-WIRB-20011156, NCI-V02-1697
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: C010, CO10, A8501022, NCT00043407
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-030104201A, CPGI-C014, CPGI-CPG7909-C014, NCT00091208
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: LYMNHL0014, 80057, NIH, NCT00185965
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Diagnostic, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000530062, MAYO-LS0382, MAYO-IRB-703-04, NCT00438880
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C017, ProMune, CO17, A8501017, NCT00070629
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C023, CO23, A8501023, NCT00070642
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: Pharmaceutical / Industry Protocol IDs: C016, CO16, A8501015, NCT00043368
|
|
9.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: LAC-USC-10M033, LAC-USC-IRB-942010, NCI-6451, 6451, NCT00085189
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A8501006, NCT00321815
|
|
11.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-0112032, CPGI-C004-CPG7909, NCI-G02-2086, NCT00040950
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LUD 2000-018, NCT00112229
|
|
13.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 200402002, NCT00233506
|
|
14.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: LUD2003-022;NYU05-120;CUMC9147, NCT00299728
|
|
15.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 05-140, 1R01CA112198-01, NCT00819806
|
|
16.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 to 55 Sponsor: NCI, Other Protocol IDs: City of Hope 03121, R01CA077544, P30CA033572, CHNMC-03121, CDR0000599724, NCI-2010-01227, 03121, NCT00722839
|
|
17.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: PCI-04173, 04-173, PCI-IRB-0607048, 7357, NCT00471471
|